stella
beta
Combination of Zanubrutinib, Rituximab and Venetoclax in Patients With Previously Untreated Follicular Lymphoma — Stella
Recruiting
Back to Ann Arbor Stage II Follicular Lymphoma trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Biotherapeutic Department and Hematology Department of Chinese PLA General Hospital, Beijing
View full record on ClinicalTrials.gov